Literature DB >> 20635367

Pontocerebellar hypoplasia type 6: A British case with PEHO-like features.

Julia Rankin1, Ruth Brown, William B Dobyns, Judith Harington, Jay Patel, Michael Quinn, Garry Brown.   

Abstract

Six subtypes of autosomal recessive pontocerebellar hypoplasia (PCH) have been identified and the genetic basis of four of these (PCH1, PCH2, PCH4, and PCH6) is known. PCH6 is associated with cerebral atrophy and multiple but variable respiratory chain defects in muscle and has been reported in one consanguineous Sephardic Jewish family. It is caused by mutations in the RARS2 gene which encodes mitochondrial arginine-transfer RNA synthetase. Here we describe a female patient born to nonconsanguineous British parents. She presented in the neonatal period with increased respiratory rate, poor feeding and transiently elevated blood and CSF lactate levels. She went on to manifest profound developmental delay and severe microcephaly. Edema of the hands, feet, and face were suggestive of a PEHO-like condition (progressive encephalopathy, edema, hypsarrhythmia and optic atrophy), although optic atrophy and hypsarrhythmia were absent. Cranial MRI at age 14 months showed generalized cerebral atrophy, thinning of the pons and gross atrophy and flattening of the cerebellar hemispheres. Muscle biopsies on two occasions were normal with normal respiratory chain studies. Despite the absence of respiratory chain defects, the phenotype was felt to be consistent with PCH6 and indeed two novel pathogenic RARS2 mutations were identified. Ours is the second report of PCH6 due to RARS2 mutations and demonstrates that respiratory chain abnormalities are not obligatory, whereas some features of PEHO might be present.

Entities:  

Mesh:

Year:  2010        PMID: 20635367     DOI: 10.1002/ajmg.a.33531

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  29 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 2.  SPTAN1 encephalopathy: distinct phenotypes and genotypes.

Authors:  Jun Tohyama; Mitsuko Nakashima; Shin Nabatame; Ch'ng Gaik-Siew; Rie Miyata; Zvonka Rener-Primec; Mitsuhiro Kato; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

Review 3.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

4.  Novel mutations in WWOX, RARS2, and C10orf2 genes in consanguineous Arab families with intellectual disability.

Authors:  Asem M Alkhateeb; Samah K Aburahma; Wesal Habbab; I Richard Thompson
Journal:  Metab Brain Dis       Date:  2016-04-28       Impact factor: 3.584

Review 5.  Human aminoacyl-tRNA synthetases in diseases of the nervous system.

Authors:  Jana Ognjenović; Miljan Simonović
Journal:  RNA Biol       Date:  2017-06-30       Impact factor: 4.652

6.  Distinct magnetic resonance imaging features in a patient with novel RARS2 mutations: A case report and review of the literature.

Authors:  Jie Zhang; Zhongbin Zhang; Yao Zhang; Ye Wu
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

7.  Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient.

Authors:  Lydie Burglen; Sandra Chantot-Bastaraud; Catherine Garel; Mathieu Milh; Renaud Touraine; Ginevra Zanni; Florence Petit; Alexandra Afenjar; Cyril Goizet; Sabina Barresi; Aurélie Coussement; Christine Ioos; Leila Lazaro; Sylvie Joriot; Isabelle Desguerre; Didier Lacombe; Vincent des Portes; Enrico Bertini; Jean-Pierre Siffroi; Thierry Billette de Villemeur; Diana Rodriguez
Journal:  Orphanet J Rare Dis       Date:  2012-03-27       Impact factor: 4.123

8.  Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate.

Authors:  Anna-Kaisa Anttonen; Taru Hilander; Tarja Linnankivi; Pirjo Isohanni; Rachel L French; Yuchen Liu; Miljan Simonović; Dieter Söll; Mirja Somer; Dorota Muth-Pawlak; Garry L Corthals; Anni Laari; Emil Ylikallio; Marja Lähde; Leena Valanne; Tuula Lönnqvist; Helena Pihko; Anders Paetau; Anna-Elina Lehesjoki; Anu Suomalainen; Henna Tyynismaa
Journal:  Neurology       Date:  2015-06-26       Impact factor: 9.910

9.  A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings.

Authors:  Zejuan Li; Rhonda Schonberg; Lucia Guidugli; Amy Knight Johnson; Stephen Arnovitz; Sandra Yang; Joseph Scafidi; Marshall L Summar; Gilbert Vezina; Soma Das; Kimberly Chapman; Daniela del Gaudio
Journal:  J Hum Genet       Date:  2015-03-26       Impact factor: 3.172

10.  RARS2 Mutations: Is Pontocerebellar Hypoplasia Type 6 a Mitochondrial Encephalopathy?

Authors:  Tessa van Dijk; Fred van Ruissen; Bregje Jaeger; Richard J Rodenburg; Saskia Tamminga; Merel van Maarle; Frank Baas; Nicole I Wolf; Bwee Tien Poll-The
Journal:  JIMD Rep       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.